Back to discover
Drug

Homocysteine thiolactone

Research stage
Emerging research
RxNorm27096ChEMBLCHEMBL3272518UNIID5H88XF24X
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Homocysteine thiolactone
RxNorm CUI
27096
ChEMBL ID
CHEMBL3272518
UNII
D5H88XF24X

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes3
Homocysteine1Parkinson Disease1Protein Deglycase DJ-11
Journals, researchers & institutions
Top journals
  • Aging cell1
Leading researchers
  • Bao A1
  • Chen G1
  • Guo T1
  • Hu D1
  • Huang J1
  • Li Y1
  • Wang ZH1
  • Xiao T1
Leading institutions
free-text, unnormalised
  • Department of Clinical Laboratory1
  • Renmin Hospital of Wuhan University1
  • Second Affiliated Hospital of Nanchang University1
  • TaiKang Center for Life and Medical Sciences1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Homocysteine

Studied across 2 of the same disease areas as Homocysteine thiolactone in the shared literature.

2 shared diseases1 shared paper
Lysine

Studied across 2 of the same disease areas as Homocysteine thiolactone in the shared literature.

2 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature